Ohshima H, Bartsch H
IARC Sci Publ. 1984(59):233-46.
Results from animal experiments and studies in human subjects indicated that the amount of nitrosoproline (NPRO) excreted in the 24-h urine, following ingestion of precursors, is an index for the rate of endogenous nitrosation; this method was found to be sensitive, reproducible and could be satisfactorily applied to human subjects in clinical and field studies. N-Nitrosothiazolidine 4-carboxylic acid (NTCA) and its 2-methyl derivative (NMTCA) were also identified in the urine of human subjects. As the respective amino precursors (thiazolidine 4-carboxylic acids) can be formed by reaction of formaldehyde or acetaldehyde with cysteine, measurement of NTCA and NMTCA in urine may provide a further index for endogenous nitrosation in the human body and may also allow monitoring of exposure of human subjects to aldehydes, nitrate and nitrite. The yield of nitroso compounds formed endogenously in the human body was shown to be linked to the intake of precursors, but several inhibitors and catalysts, either as pure substances or occurring in complex mixtures, were shown to modify the nitrosation reaction in vivo. In particular, ingestion of ascorbic acid after nitrate-rich meals was efficient in lowering human exposure to endogenously formed N-nitroso compounds. A dose-response relationship was established for the formation of NPRO in rats in vivo, after concurrent administration of various concentrations of the precursors, L-proline and sodium nitrite. The logarithm of the amount of NPRO formed was found to be proportional to the logarithm of the product of the proline dose and the square of the nitrite dose. On the basis of these results, a kinetic model was formulated allowing the estimation of the daily precursor dose quantity, ([amine][nitrite]2), required to give 50% tumour incidence in rats after two years of feeding. The potential application of this model, for the estimation of carcinogenic risk from endogenously formed N-nitrosamines in humans, is discussed. Our results demonstrate unequivocally the endogenous formation of N-nitroso compounds in the human body, the significance of which in human carcinogenesis remains to be established.
动物实验和人体研究结果表明,摄入前体物质后,24小时尿液中排出的亚硝基脯氨酸(NPRO)量是内源性亚硝化速率的一个指标;该方法被发现具有敏感性、可重复性,并且可以令人满意地应用于临床和现场研究中的人体受试者。在人体受试者的尿液中还鉴定出了N-亚硝基噻唑烷-4-羧酸(NTCA)及其2-甲基衍生物(NMTCA)。由于各自的氨基前体(噻唑烷-4-羧酸)可通过甲醛或乙醛与半胱氨酸反应形成,因此测量尿液中的NTCA和NMTCA可能为人体内源性亚硝化提供进一步的指标,也可能有助于监测人体受试者对醛、硝酸盐和亚硝酸盐的暴露情况。人体内生性形成的亚硝基化合物产量显示与前体物质的摄入量有关,但几种抑制剂和催化剂,无论是作为纯物质还是存在于复杂混合物中,都显示会在体内改变亚硝化反应。特别是,在富含硝酸盐的膳食后摄入抗坏血酸能有效降低人体对内源性形成的N-亚硝基化合物的暴露。在同时给予大鼠不同浓度的前体物质L-脯氨酸和亚硝酸钠后,建立了大鼠体内NPRO形成的剂量反应关系。发现形成的NPRO量的对数与脯氨酸剂量和亚硝酸盐剂量平方的乘积的对数成正比。基于这些结果,建立了一个动力学模型,可用于估计在两年喂养后使大鼠肿瘤发生率达到50%所需的每日前体剂量量([胺][亚硝酸盐]²)。讨论了该模型在估计人体内生性形成的N-亚硝胺致癌风险方面的潜在应用。我们的结果明确证明了人体中N-亚硝基化合物的内源性形成,其在人类致癌作用中的意义仍有待确定。